Elevance Health ELV 深 滬
等待開盤 06-24 09:30:00 美东时间
395.10
+0.280
+0.07%
華盛通- 最 高399.28
- 今 開398.88
- 成交量 125.70万股
- 最 低 393.28
- 昨 收 394.82
- 總市值 8580.09万
- 52周最高 426.98
- 市盈率 靜 15.67
- 換手率 0.58%
- 52周最低 266.85
- 委 比 -81.82%
- 總股本 0.00亿
- 歷史最高 553.72
- 量 比 0.77
- 振 幅 1.52%
- 歷史最低 1.105
- 每 手 1
- 風險率 35.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多瑞银拆解医疗AI红利：AI难以成为险企“护城河”，医院反成最大赢家
瑞银近日发布报告指出，人工智能(AI)正逐步成为医疗健康领域的底层核心技术，但本轮技术变革的最大受益者并非医疗保险公司，医院反而有望依托AI构筑更稳固的长期竞争...
06-22 08:48
AI may help hospitals more than insurers, UBS says
Artificial intelligence is poised to become a foundational technology across healthcare, but the biggest winners may not be health insurers. Instead, hospitals could emerge with a more durable competi...
06-22 00:00
Elevance Health Invests $640M In Affordable Housing Over The Past Five Years, Building On More Than $1B Invested Over Nearly Two Decades
Elevance Health (NYSE:ELV) today announced it has invested $640 million in affordable housing over the past five years, building on more than $1 billion invested over nearly two decades. These investments reflect the company's continued commitment to addressing social drivers of health, helping lowe...
06-17 22:03
Elevance Health Inc(ELV)股票6月10日盘中下跌5.03%：原因全解读
• Elevance Health重申了2026年业绩指引，但公司股价仍出现下跌。 • 市场逆风和对估值的担忧共同影响了股价表现。 • 过往的监管问题和投资者的谨慎态度可能会持续存在。
06-10 19:16
Elevance Health expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS of at least $26.75 per share.
Elevance Health (NYSE:ELV) expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS of at least $26.75 per share.
06-10 18:33
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $435 to $465.
06-09 01:35
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $450
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $375 to $450.
06-01 22:20
